India Inc eyes US market

With Donald Trump set to become the next American President, India Inc on Wednesday sought greater access for the country’s pharmaceutical products in the US market and mobility of skilled labour.

The industry also tried to allay concerns related to the billionaire businessman, expressing confidence that apprehensions linked to him would “certainly prove wrong”, saying it looks forward to take the bilateral economic engagement to a greater level under the Trump administration.

“We hope that challenges relating to mobility of skilled labour, market access for pharmaceutical products from India, and financial services institutions and SMEs will be addressed,” CII president Naushad Forbes said.

“Our primary focus areas with the US have been standards, manufacturing competitiveness, defence collaboration and mobility of high skilled labour. We look forward to working with the Trump administration to further cement this critical partnership.”

Seeking to “bind the wounds of division” after a bitter and divisive campaign, Mr Trump pledged to be the President for all Americans.